Proteomics

Dataset Information

0

Quantification of glycated human serum albumin peptides


ABSTRACT: Human serum albumin is the most abundant plasma protein with a large number of lysine and arginine residues. Hence, it is highly susceptible to glycation in vivo. In hyperglycemic conditions, such as diabetes, the level of HSA glycation increases. Here we quantified glycated HSA peptides in a subject population of healthy and type 2 diabetes with and without nephropathy to assess its performance for the diagnosis of diabetic nephropathy compared to HbA1c.

INSTRUMENT(S): TripleTOF 5600

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

SUBMITTER: Arvindkumar Chaurasiya  

LAB HEAD: Mahesh J Kulkarni

PROVIDER: PXD040028 | Pride | 2023-07-20

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Diabetic.csv Csv
Diabetic.zip Other
Diabetic_nephropathy.csv Csv
Diabetic_nephropathy.zip Other
Healthy.csv Csv
Items per page:
1 - 5 of 7
altmetric image

Publications

Elevated Level of Glycated KQTALVELVK Peptide of Albumin Is Associated with the Risk of Diabetic Nephropathy.

Chaurasiya Arvindkumar H AH   Jaiswal Meera R MR   Bayatigeri Santhakumari S   Kahar Shweta S   Tiwari Shalbha S   Unnikrishnan Ambika G AG   Kulkarni Mahesh J MJ  

ACS omega 20230601 23


Diabetic nephropathy is a leading cause of end-stage renal disease. Hence, early detection of diabetic nephropathy is essential to mitigate the disease burden. Microalbuminuria, the currently used diagnostic marker of diabetic nephropathy, is not efficient in detecting it at an early stage. Therefore, we explored the utility of glycated human serum albumin (HSA) peptides for risk prediction of diabetic nephropathy. Three glycation-sensitive HSA peptides, namely, FKDLGEENFK, KQTALVELVK, and KVPQV  ...[more]

Similar Datasets

2011-11-11 | PRD000401 | Pride
2017-01-02 | PXD004182 | Pride
2014-02-14 | E-GEOD-48318 | biostudies-arrayexpress
2020-01-09 | PXD015101 | Pride
2018-05-30 | PXD009345 | Pride
2016-01-11 | PXD003054 | Pride
2022-12-13 | PXD038794 |
2019-07-08 | PXD014334 | Pride
2024-10-17 | PXD052096 | Pride
2023-07-06 | PXD041212 | Pride